2 coronavirus vaccine success stocks I think could make UK investors rich

I think investing in these two stocks will bring success regardless of which company wins the race to develop a coronavirus vaccine.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Of the 100+ coronavirus vaccines under investigation, some, like the one being developed by Oxford University and AstraZeneca, are showing real promise in clinical trials. In fact, Russia granted regulatory approval for a vaccine yesterday, although doubt has been expressed about the approval process and the efficacy of the vaccine.

Holding the stock of the company that develops a vaccine first might seem like the path to profit. However, some developers are private. Others are public companies but their stock is difficult to trade for UK investors. Those aren’t the only hurdles to successfully picking a successful coronavirus vaccine investment.

Coronavirus vaccine success

Developing a vaccine is one thing. Mass producing it is another. An investor might be able to back the right developer, only for them to struggle to produce enough doses. A company cannot truly win the vaccine race if multiple vaccines are approved. Another issue is that developers are rightly making promises to sell at least a chunk of vaccines at cost. 

To my mind, a better bet for profiting from a coronavirus vaccine is to back stocks that will do well regardless of who wins the vaccine race. Getting the world back to normal will happen faster with a vaccine than without one. Travel and leisure stocks were particularly badly hit by the coronavirus market crash. It stands to reason that they should benefit substantially from a return to normality, particularly if it does not take as long as had been feared.

Stocks that win regardless

I think InterContinental Hotels is a potential coronavirus vaccine success stock. It already has 95% of its sites open for business. Although the company reported a loss of $275m for the first half of 2020, this was not as bad as expected and included $255m in exceptional, and mainly non-cash, charges. A free cash outflow of $66m over the first six months of this year was better than expected.

Domestic travel is recovering faster than international. IHG’s core US business is benefitting from this, as are its other operations in countries across the world. IHG owns hotel brands that cater to every segment, from budget domestic right up to luxury international. Therefore it will cumulatively pick up revenues as different groups of travellers get back on the road, even without a vaccine. With a vaccine, IHG’s share price should get a real boost and shareholders would start receiving dividends sooner.

Another stock I think could boom with a coronavirus vaccine is National Express. After a strong bounce back from the depth of the coronavirus market crash, the share price of the US and European coach, school bus, and rail service operator has slumped again. A departing CEO selling his shares did not help. However, National Express earned record sales and profits in 2019, after a near decade-long turnaround.

National Express has slashed costs, raised equity, and has about £1.5bn in cash and credit. The company looks well-positioned for a staged recovery in travel. Again, this stock has the advantage of drawing a lot of business from domestic travel. A coronavirus vaccine will return the world closer to normal patterns of travel much quicker and should give the National Express share price a real boost.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

James J. McCombie owns shares of National Express Group. The Motley Fool UK has recommended InterContinental Hotels Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

3 of my top FTSE 250 stocks to consider buying before April

Buying undervalued UK shares can be a great way to generate long-term wealth. Here, Royston Wild reveals a handful on…

Read more »

Ice cube tray filled with ice cubes and three loose ice cubes against dark wood.
Investing Articles

Just released: our 3 top income-focused stocks to buy before April [PREMIUM PICKS]

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due…

Read more »

Investing Articles

Is this the best chance to buy cheap FTSE 100 shares in a generation?

I want to buy shares when they're cheap, and sell... never, just keep taking the dividends. And the FTSE 100…

Read more »

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

Could NatWest shares be 2024’s number one buy for passive income?

For those of us looking to earn some long-term passive income, how does NatWest's 7% dividend yield sound? It sounds…

Read more »

Investing Articles

£12K in savings? Here’s how I could turn that into £13K annual passive income

This Fool explains how investing a lump sum can help her build a passive income stream to enjoy in her…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Here’s why Rolls-Royce shares are now set to fly over the £4 mark

Once again, Rolls-Royce shares are crushing the FTSE 100. Should I add to my holding of this stock at the…

Read more »

Investing Articles

1 under the radar FTSE 100 AI stock investors should consider buying

Our writer explains why this FTSE 100 pick could be a shrewd investment with its established experience of using AI…

Read more »

Investing Articles

Does the beaten-down Diageo share price make it a no-brainer buy?

Harvey Jones spent years waiting for the Diageo share price to look like good value, before finally buying it in…

Read more »